b-Catenin is a key integrator of cadherin-mediated cell-cell adhesion and transcriptional regulation through the Wnt/ b-catenin pathway, which plays an important role in liver biology. Using a model of contact-inhibited liver progenitor cells, we examined the interactions of Wnt/b-catenin signaling with the aryl hydrocarbon receptor (AhR), a ligand-activated transcription factor, which mediates the toxicity of dioxin-like compounds, including their effects on development and hepatocarcinogenesis. We found that AhR and Wnt/b-catenin cooperated in the induction of AhR transcriptional targets, such as Cyp1a1 and Cyp1b1. However, simultaneously, the activation of AhR led to a decrease of dephosphorylated active b-catenin pool, as well as to hypophosphorylation of Dishevelled, participating in regulation of Wnt signaling. A sustained AhR activation by its model ligand, 2, 3, 7, , led to a downregulation of a number of Wnt/b-catenin pathway target genes. TCDD also induced a switch in cytokeratin expression, where downregulation of cytokeratins 14 and 19 was accompanied with an increased cytokeratin 8 expression. Together with a downregulation of additional markers associated with stem-like phenotype, this indicated that the AhR activation interfered with differentiation of liver progenitors. The downregulation of b-catenin was also related to a reduced cell adhesion, disruption of E-cadherinmediated cell-cell junctions and an increased G1-S transition in liver progenitor cell line. In conclusion, although b-catenin augmented the expression of selected AhR target genes, the persistent AhR activation may lead to downregulation of Wnt/ b-catenin signaling, thus altering differentiation and/or proliferative status of liver progenitor cells.
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The armadillo protein b-catenin is known as a linker of cadherins and a-catenin and as a crucial mediator of canonical Wnt signaling (Clevers, 2006; Heuberger and Birchmeier, 2010) . Through modulation of both cell-cell adhesion and transcription, it participates in the regulation of embryonic development, adult tissue self-renewal, and stem cell maintenance. The Wnt/b-catenin pathway signaling proceeds through the inactivation of cytoplasmic destruction complex consisting of axins, adenomatous polyposis coli and associated kinases, casein kinase 1 (CK1)a, and glycogen synthase kinase 3b (GSK3b). The inactivation of this complex leads to cytoplasmic stabilization and nuclear translocation of b-catenin. It then forms transcriptionally active complex with lymphoid enhancer binding factor/T-cell factors (Clevers, 2006) . In liver, the Wnt/ b-catenin pathway has been implicated in regulation of development, growth, and regeneration (reviewed in Thompson and Monga, 2007) , as well as in control of liver zonation, metabolism, and activation of adult hepatic stem cells (Apte et al., 2008; Benhamouche et al., 2006; Hailfinger et al., 2006; Hu et al., 2007; Yang et al., 2008) . The aberrant activation of b-catenin has been shown to contribute to the development of a range of liver tumors (Thompson and Monga, 2007) .
Several lines of evidence hint at existence of interplay between Wnt signaling and the aryl hydrocarbon receptor (AhR). This ligand-activated transcription factor mediates the toxicity of numerous environmental contaminants, including polychlorinated dibenzo-p-dioxins and polycyclic aromatic hydrocarbons, and it plays a crucial role in regulation of cytochrome P450 (CYP) family 1 enzymes (Nebert and Dalton, 2006) . Nevertheless, apart from its role in regulation of metabolism, AhR has been reported also to actively participate in regulation of cell cycle, apoptosis, intercellular communication, and cellular motility (for recent reviews, see e.g., Dietrich and Kaina, 2010; Kung et al., 2009) . Toxic AhR ligands, such as 2, 3, 7, , are powerful liver tumor promoters and, in the absence of ligand, AhR behaves as a tumor suppressor in liver (Fan et al., 2010) . AhR itself is a Wnt/b-catenin target gene (Chesire et al., 2004) , and the canonical Wnt/b-catenin pathway has been suggested to be a regulator of hepatic CYP expression (Braeuning et al., 2009; Hailfinger et al., 2006; Loeppen et al., 2005) . The AhR activation has been also shown to induce a misexpression of Wnt signaling pathway members (Mathew et al., 2008) , and recently, Kawajiri et al. (2009) have reported that AhR may suppress intestinal carcinogenesis through degradation of b-catenin. Thus, the available data seem to imply that b-catenin may modulate the AhR-mediated transcription and, vice versa, the activated AhR may affect Wnt/b-catenin pathway components; however, the exact impact of AhR activation on deregulation of b-catenin function related to Wnt signaling or cell-cell adhesion is largely unknown.
Based on the proposed function of AhR as a regulator of stem/progenitor cell populations (Singh et al., 2009) , we hypothesized that the interplay of AhR and b-catenin might modulate functions of liver progenitors. Rat liver WB-F344 cells are a well-characterized in vitro model of rodent hepatic progenitor cells, which retains the capacity to differentiate into both biliary and hepatic lineages (Shafritz and Dabeva, 2002; Tsao et al., 1984) . They are highly sensitive to various types of AhR ligands, which induce expression of CYP1 enzymes and disrupt cell cycle control in contact-inhibited WB-F344 cells (Andrysík et al., 2007; Vondráček et al., 2005; Weiss et al., 2008) . In the present study, we have used this cellular model in order to analyze the interactions of AhR and Wnt/b-catenin in AhR-dependent transcriptional regulation and the impact of sustained AhR activity on Wnt/b-catenin signaling. Our results suggest that in a model of liver progenitors, the activated AhR and canonical Wnt signaling coordinately upregulate expression of AhR target genes, such as Cyp1a1 and Cyp1b1. In contrast, a sustained activation of AhR by TCDD may downregulate the Wnt/b-catenin signaling and alter liver progenitor cell phenotype. The observed dual interplay between both signaling pathways might contribute to toxic effects of AhR ligands in progenitor cell populations.
MATERIALS AND METHODS
Cell culture and treatments. WB-F344 cells (Tsao et al., 1984) were kindly provided by James E. Trosko (Michigan State University, East Lansing, MI). The cells were maintained as previously described (Zatloukalová et al., 2007) . For the experiments, cells were seeded at the density of 30,000 cells/cm 2 and grown until they were fully confluent. The medium was exchanged, and after another 24 h of incubation, cells were treated with indicated compounds or solvent as a control. TCDD was from Cambridge Isotope Laboratories (Andover, MA). The CK1 inhibitor D4476 was from Calbiochem (San Diego, CA) and it was used according to established protocol (Bryja et al., 2007) . The proteasome inhibitor MG132 was from Sigma-Aldrich (Prague, Czech Republic). For small interfering RNA (siRNA) knockdown of AhR and b-catenin, cells were transfected with Lipofectamine 2000 (Invitrogen, Carlsbad, CA), as previously described (Andrysík et al., 2007) . The sequences of siRNAs directed against rat AhR and b-catenin are reported elsewhere (AleAgha et al., 2009; Weiss et al., 2008) . As a control, we used the off-target 5#-UUCUCCGAACGUGUCACGUtt-3# siRNA.
Real-time reverse transcription-PCR. Real-time reverse transcription (RT)-PCR was performed using the SuperScript III Platinum One-Step Quantitative RT-PCR kit (Invitrogen). For the information on primer pairs and probes used for detection of specific transcripts, see Supplementary data.
Western blotting. At the end of each treatment, whole-cell lysates were prepared with SDS lysis buffer (1% SDS, 10% glycerol vol/vol, 100mM Tris, pH 7.4), and protein concentration was estimated using Bio-Rad DC Protein Assay (Bio-Rad Laboratories, Inc., Hercules, CA). For preparation of nuclear extracts, treated cells were washed with PBS and lysed with lysis buffer (Tris 10mM, KCl 60mM, EDTA 1.2mM, dithiothreitol [DTT] 1mM; pH 8.0), supplemented with 100lM PMSF and 1mM NP-40, for 10 min on ice, and centrifuged. The supernatants were used to estimate cytosolic fractions. The pellets were further rinsed with lysis buffer without PMSF and NP-40, centrifuged, and incubated for 25 min in 50 ll of nuclear extraction buffer (Tris 20mM, NaCl 420mM, MgCl 2 0.7mM, EDTA 0.25mM; glycerol 25% vol/vol) on ice. After final centrifugation, supernatants were collected and stored frozen in aliquots at À80°C. All samples were separated by 10 % SDS-PAGE and transferred to polyvinylidene difluoride membrane (Millipore, Prague, Czech Republic). Specific proteins were detected with the following antibodies: antiAhR (ENZO Life Sciences, Plymouth Meeting, PA); anti-Cyp1a1, antiCyp1b1, and anti-E-cadherin (BD Biosciences, San Jose, CA); anti-b-catenin, anti-phosphoS1490-low-density lipoprotein receptor-related protein 6 (pLRP6), anti-GSK3b, and anti-phosphoS9-GSK3b (Cell Signaling Technology, Beverly, MA); anti-Dishevelled 2 (Dvl2) and anti-Dvl3 (Santa Cruz Biotechnology, Santa Cruz, CA); anti-active-b-catenin clone 8E7 (Millipore); and anti-b-actin (Sigma-Aldrich). The secondary antibodies, conjugated with horseradish peroxidase and ECL-Plus reagent, were purchased from GE Healthcare (Little Chalfont, UK) and were used according to the manufacturer's instructions. Densitometry of total and active b-catenin (ABC) forms was performed with ImageJ image analysis software (http://rsb.info.nih.gov/ij/index.html).
Immunocytochemistry. AhR cellular localization was examined by indirect immunofluorescence using anti-AhR antibody and anti-rabbit Alexa 488-coupled fluorescent antibody (Molecular Probes, Carlsbad, CA) diluted in tris-buffered saline buffer (20mM Tris.Cl, 145mM NaCl; pH 7.4). For detection of ABC, we used anti-ABC antibody and anti-mouse Alexa 488-coupled fluorescent antibody (Molecular Probes). The precise protocol has been described previously (Zatloukalová et al., 2007) . Cells were mounted in 5 ll of Mowiol mixture (Calbiochem) solution and visualized with an Olympus IX70 fluorescence microscope.
Chromatin immunoprecipitation. DNA-protein complexes were crosslinked with 1% formaldehyde, isolated using buffer C (20mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid, pH 7.9, 25% glycerol, 420mM NaCl, 1.5mM MgCl 2 , 0.2mM EDTA, 1mM PMSF), sonicated in breaking buffer (50mM Tris.Cl, pH 8.0, 1mM EDTA, 150mM NaCl, 1% SDS, 2% Triton X-100), and incubated with Protein A-Sepharose 4B beads (SigmaAldrich) in Triton buffer (50mM Tris.Cl, pH 8.0, 1mM EDTA, 150mM NaCl, 0.1% Triton X-100) overnight at 4°C for nonspecific binding. Precleared supernatants were then incubated with beads and 2 lg of anti-AhR antibody or no antibody for 6 h. To isolate DNA, we incubated precipitates and inputs in elution buffer (62.5mM Tris.Cl, pH 6.8, 200mM NaCl, 2% SDS, 10mM DTT) at 65°C overnight, then performed phenol-chloroform and chloroform extractions, and finally purified DNA with ethanol. DNA samples were dried and dissolved in water and amplified using recombinant Taq DNA polymerase (Fermentas, Ontario, Canada) and specific primers corresponding to the rat Cyp1a1 enhancer region: forward primer 5#-CAGGCCTTTGCTCTCAGG-3# and reverse primer 5#-CACCCAGCTACCCAACTCAC-3# or the rat Cyp1b1 enhancer region: forward primer 5#-GTTGGGTTGAAAAGTTTCTGCT-3# and reverse primer 5#-GAGATGACTGGAGCCGACTT-3#. The following thermal cycler (MJ Research, GMI, Ramsey, MN) program was used: initial denaturation 95°C for 3 min, followed by cycling 95°C 30 s, 58°C 30 s, 72°C 1 min for 30 times, and final extension 72°C for 2 min. Amplified DNA was separated in 2% agarose gel stained with ethidium bromide in 1 3 TAE buffer (40mM Tris-acetate, 1mM EDTA).
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Cell cycle analysis and detection of proliferation. For cell cycle analysis and determination of numbers of WB-F344 cells, we used propidium iodide staining of DNA, followed by flow cytometric analysis, and counting of cells with Coulter Counter (Model ZM, Coulter Electronics, Luton, UK), respectively. Cells were harvested by trypsinization at indicated times, and both DNA content and cell numbers were then assessed as described previously (Zatloukalová et al., 2007) .
Cell adhesion assay using impedance technology. In order to monitor cell adhesion in both time-and treatment-dependent manner, confluent WB-F344 cells were treated with DMSO (0.1%) and TCDD 5nM for 48 h. Cells were then harvested by trypsinization and seeded at density 5 3 10 4 per well (0.2 cm 2 ) in 16-well E-plates (Roche Diagnostics GmbH, Mannheim, Germany) in two-independent triplicates. Using xCELLigence system (Roche) equipped with RTCA software 1.2 (ACEA Biosciences), the cellular impedance was recorded for next 24 h according the following schedule: step 1 -time 1 min -sweep 1 (background measurement), step 2a -time 10 minsweep 73 (step duration 12 h), and step 2b -time 20 min -sweep 36 (12 h). The cell index (CI) parameter demonstrates the ability of cells to adhere, spread, and proliferate. The formula for CI calculation as well as the principle of data assessment and their interpretation have been described previously (Atienza et al., 2005) . The CI values were recorded every 10 min for the first 3 h (the time interval reflecting cell adhesion and spreading), and they were then expressed either as raw CI values at specific time points (CI/time) or as a slope parameter in 0-to 3-h time period (1/time). Slope values at the time period 0-3 h were used to determine the statistical significance (p < 0.01) between DMSO-and TCDD-treated cells using one-way ANOVA and Holm-Sidak post hoc test.
Statistical analysis. For statistical analysis, we used Student's t-test or one-way ANOVA followed by Dunnet's or Tukey's post hoc tests. Differences were considered significant when p < 0.05.
RESULTS
The Contact-Inhibited WB-F344 Cells Show a Constitutive Activation of Wnt/b-Catenin Pathway, which Can Be Further Promoted by Wnt3a Stimulation As outlined in Figure 1A , in contact-inhibited WB-F344 cells, recombinant mouse Wnt3a, which is the ligand of the Wnt/b-catenin pathway, induced a rapid phosphorylation of Wnt coreceptor, LRP6, and the accumulation of the ABC form, which is dephosphorylated on S37 and T41. Formation of phosphorylated LRP6 (pLRP6) is one of the most sensitive readouts of the Wnt/b-catenin pathway activation. The pLRP6 form was present also in untreated cells, which indicated a constitutive activity of the Wnt signaling. This assumption was further confirmed by the analysis of the cytoplasmic proteins Dvl, which participate in the activation of LRP6 and subsequent inhibition of b-catenin cytoplasmic destruction complex and b-catenin stabilization (Bryja et al., 2007; Wallingford and Habas, 2005) . Our data demonstrate that Dvl2 is present in its active phosphorylated form in WB-F344 cells, as indicated by a visible downshift/dephosphorylation of Dvl2 after inhibition of dominant Dvl kinase CK1 by CK1-specific inhibitor D4476. In line with the previous findings, CK1 inhibition reduced also both basic and Wnt3a-induced LRP6 phosphorylation, which is a consequence of Dvl phosphorylation. These observations together suggested that Wnt signaling is inherently active in WB-F344 cells upstream of Dvl phosphorylation. Nevertheless, neither the WB-F344-derived culture medium nor the cells themselves (when cocultivated with target cells transfected with TOPFlash reporter) induced TOPFlash reporter activity (Supplementary fig. 1 ). This excluded the possibility that the increased Wnt pathway activity was due to autocrine or paracrine production of canonical Wnts. The induction of robust LRP6 phosphorylation and accumulation of ABC by recombinant Wnt3a, as well as the efficient induction of Axin2 and Cyclin D1 messenger RNAs (mRNAs) (Fig. 1B) , suggested that the confluent WB-F344 cells are highly sensitive to exogenous canonical Wnts. This encouraged us to study impact of Wnt3a on various AhR-regulated end points in WB-F344 cells. The AhR activation leads to induction of proliferation of contact-inhibited WB-F344 cells (Weiss et al., 2008) . Wnt3a was also able to minorily induce proliferation in contact-inhibited WB-F344 cells, which corresponded with increased levels of S-phase-specific Cyclin A. However, this increase in cell numbers was significantly smaller than the one induced by TCDD, and the two stimuli did not synergize in the induction of cell proliferation (Figs. 1C and 1D) , although the expression of Cyclin A was higher in cotreated cells.
Recombinant Wnt3a Potentiates the TCDD-Induced Cyp1a1/ 1b1 Expression without Altering AhR Nuclear Translocation or AhR-DNA Binding
Recombinant Wnt3A increased AhR levels in WB-F344 cells as shown in Figures 2A and 2D . However, the basal AhR expression was probably independent of b-catenin action, as the siRNA-mediated knockdown of b-catenin had no effect on AhR levels (Supplementary fig. 2A ). Wnt3a strongly augmented the TCDD-induced expression of both Cyp1a1 and Cyp1b1 mRNAs and protein ( Figs. 2A and 2B ). Wnt3a itself was able to slightly increase Cyp1a1, but not Cyp1b1 mRNA levels, and this increase was not significant. These results suggested an interactive action of ABC and AhR in the regulation of Cyp1 enzymes. However, we did not observe any major alteration of AhR binding to Cyp1a1 or Cyp1b1 enhancers as documented by the results of ChIP assay after 1-h treatment (Fig. 2C) . Furthermore, Wnt3a did not affect nuclear translocation of AhR, although we observed enhanced accumulation of AhR in Wnt3a-treated cells after 24 h of treatment, corresponding with the Western blotting results (Figs. 2D and 2A) . The activated AhR and b-catenin may interact in nuclei of liver progenitor cells, where both proteins are present at sufficient levels upon AhR activation (Supplementary fig. 2B ). The existence of active AhR/b-catenin interaction is supported by our finding that overexpressed constitutively active AhR mutant physically interacts with endogenous b-catenin, as documented by the coimmunoprecipitation experiments performed in COS-7 cells (Supplementary fig. 3 ). (Fig. 3A) . However, TCDD efficiently downregulated ABC levels both in untreated and Wnt3a-treated cells at 24 h (Fig. 3A) , although there were no significant effects of TCDD at earlier time points. A densitometry analysis also confirmed that, unlike total b-catenin, the ABC form was, after 24 h, significantly downregulated also in cells simultaneously treated with Wnt3a (inducing the accumulation of both total and ABC) and TCDD (Fig. 3B) . The dephosphorylated form of b-catenin was distributed both throughout cell membranes and in nuclei of confluent WB-F344 cells, and we observed enhanced accumulation of this b-catenin form in nuclei of the Wnt3a-treated cells (Fig. 3C) . TCDD seemed to preferentially reduce the nuclear, ABC form, and this trend could be partially observed also in nuclear/cytoplasmic fractions of WB-F344 cells analyzed by Western blotting (Supplementary fig. 2B ). It should be noted that immunocytochemistry experiments showed that there was still a substantial amount of b-catenin in cytoplasmatic membrane, suggesting that even 24 h after TCDD exposure, dioxin only partially affected b-catenin levels. In general, ABC reduction was more pronounced after longer incubations (Supplementary fig. 5 ). In contrast to the protein data, we did not observe any significant reduction of b-catenin mRNA levels up to 72 h (data not shown). TCDD itself did affect neither phosphorylation/activity nor protein levels of GSK3b, and it had no effect on phosphorylation status of LRP6 coreceptor (Fig. 3D) . In contrast, we observed an increased accumulation of downshifted/dephosphorylated Dvl2 and 3 forms, as early as 8 h after TCDD addition (Fig. 3D) , suggesting that, apart from b-catenin downregulation, TCDD inhibits further proximate Wnt signaling events. The partial decrease in b-catenin protein levels induced by TCDD was dependent on AhR activation because it was not observed in cells where AhR levels were reduced by AhR siRNA, which inhibited induction of AhR transcriptional targets, such as Cyp1a1 (Fig. 4A) . We also observed that inhibition of proteasome with MG132 inhibitor (that was added 6 h prior to harvesting the cells) did not prevent downregulation of active-b-catenin by TCDD at 24-h period, although the same cotreatment efficiently prevented AhR degradation (Fig. 4B) . This indicated that downregulation of ABC in WB-F344 cells did not depend on proteasomal activity, although these data should be interpreted with caution, as we have observed that (Supplementary fig. 4 ).
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Persistent AhR Activation Reduces mRNA Levels of Wnt/ b-Catenin Target Genes, Disrupts Cytokeratin Expression Pattern, and Downregulates Expression of Kitl and Ncam1
Based on the list of canonical Wnt pathway transcriptional targets (www.stanford.edu/~rnusse/wntwindow.html) and our own preliminary analysis of global gene expression data in WB-F344 cells, we next examined the expression of the genes that are known to be regulated by canonical Wnts. As outlined in Figure 5A , expression of Axin2, Ccnd1, Lef1, Efnb1, Fgf9, and Cyp2e1 was induced by recombinant Wnt3a after short-term incubation, thus confirming that these genes are either direct or indirect targets of Wnt/b-catenin signaling in WB-F344 cells. As shown in Figure 5B , a sustained activation of AhR by TCDD significantly reduced levels of all of these b-catenin transcriptional targets after 72 h. We selected this time point for gene expression analysis because we have observed even more pronounced ABC downregulation at this time point (Supplementary fig. 5 ).
We further investigated the consequences of AhR-mediated decrease of the Wnt/b-catenin activity for progenitor cell phenotype. Cytokeratins 14 and 19 are abundantly expressed in rat adult liver stem cells, and their downregulation is associated with progression to a more advanced differentiated phenotype 
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PROCHÁ ZKOVÁ ET AL. (Bisgaard et al., 1994; Golding et al., 1995) . As shown in Figure 6A , a sustained AhR activation markedly reduced expression of both Krt14 and Krt19, whereas it significantly increased expression of Krt8, a major hepatocyte type 2 cytokeratin, after 72 h. The reduction of Krt14 and Krt19 mRNAs, significant already after 24 h (data not shown), suggested that WB-F344 lose expression of these oval cell markers. In order to confirm that original Krt19 mRNA levels can be restored by activation of canonical Wnt signaling, we treated WB-F344 cells for 24 h with TCDD alone or in combination with recombinant Wnt3a. Wnt3a significantly increased Krt19 mRNA levels, and it restored Krt19 expression in TCDD-treated cells to control levels (Fig. 6B) . Taken together, these data indicated that activated AhR may disrupt the role of b-catenin in regulation of progenitor cell phenotype, leading to a progression into more differentiated liver cell types. This is further supported by our finding that TCDD reduced expression of other markers associated with adult hepatic stem cells, such as Kitl (stem cell factor) or Ncam1 (neural cell adhesion molecule 1) (Fig. 6C) .
b-Catenin Depletion Reduces Cell Adhesion and Enhances G1-S Transition in Confluent WB-F344 Cells
To further elucidate the functional consequences of b-catenin deregulation, we next evaluated its impact on cadherin/catenin-mediated junctions and cell adhesion. Using cell adhesion assay based on impedance technology, we observed that TCDD-treated cells have reduced cell adhesion, as compared with solvent-treated cells (Figs. 7A and 7B) . A prolonged TCDD treatment (48 h) led to a partial reduction of b-catenin and E-cadherin protein levels (Fig. 7C) . The siRNA mediated b-catenin knockdown reduced E-cadherin levels thus suggesting that b-catenin downregulation may destabilize adherens junctions (Fig. 7D) . Moreover, the b-catenin knockdown led to enhancement of G1-S transition in WB-F344 cells, which were already confluent at the time of cell cycle analysis (Fig. 7E) . Collectively, these results suggested that the downregulation of b-catenin is an inherent part of disruption of intercellular communication and cell adhesion, which is induced by persistent AhR activation in contact-inhibited WB-F344 cells.
DISCUSSION
In the present study, we used a defined in vitro model of liver adult epithelial cells with stem cell properties, in order to analyze the interactions of AhR and Wnt/b-catenin, two signaling pathways, which are both known to have profound effects on liver cells, including both regenerative and carcinogenic processes. We observed that Wnt/b-catenin activation potentiated the TCDD-mediated Cyp1a1 and 1b1 mRNA and protein induction. AhR is known to be b-catenin transcriptional target (Chesire et al., 2004) , and liver-specific Ctnnb1 knockouts show diminished AhR mRNA levels, as well as reduced Cyp1a1/1a2 expression/induction (Braeuning et al., 2009) . Here, we show that Cyp1b1 enzyme, whose transcriptional regulation notably differs from that of Cyp1a1 isoform (Sissung et al., 2006) , is also more potently induced by a combination of Wnt3a and TCDD. However, the observed enhanced induction of both AhR transcriptional targets cannot be explained simply by upregulation of AhR expression, as it occurred prior to any major increase of AhR in cells treated with Wnt3a (Fig. 2) . The activation of b-catenin did not increase either AhR nuclear translocation or its binding to specific dioxin responsive elements located in enhancer regions of Cyp1a1 and Cyp1b1 genes. Instead, our results indicate that enhanced induction of Cyp1a1/1b1 might be related to a physical interaction between activated AhR and b-catenin, as suggested by our observation that constitutively active AhR mutant coimmunoprecipitates with b-catenin. While this manuscript was under revision, a study of Braeuning et al. (2011) has been published, which addressed the coordinate regulation of Cyp1a1 by AhR and b-catenin. These authors have also concluded, using alternative liver cell models, that b-catenin signaling does not enhance AhR-DNA interaction, and that there exists a physical interaction between b-catenin and AhR, thus suggesting that b-catenin may act as a coactivator of AhR, thus enhancing transactivation potential of the AhR (Braeuning et al., 2011) . Because both Cyp1a1 and 1b1 participate in bioactivation of numerous mutagenic and carcinogenic compounds (Nebert and Dalton, 2006) , their coordinated upregulation by AhR and b-catenin might contribute to environmental carcinogenesis in tissues with high endogenous b-catenin activity.
WB-F344 cells, a model of adult hepatic stem cells, are sensitive to activation of canonical Wnt-signaling . In the present study, we demonstrated that Wnt signaling is partially active in contact-inhibited WB-F344 cells, as illustrated by increased basal LRP6 phosphorylation, elevated ABC and presence of phosphorylated Dvl forms (Fig. 1) . However, in contrast to Cyp1a1/1b1 induction, Wnt/ b-catenin pathway did not synergize with TCDD in disruption of contact inhibition. The activation of AhR by TCDD led to a significant decrease of ABC (its form dephosphorylated on S37 and T41 residues), which was evident both in untreated and Wnt3a cotreated cells (Fig. 3) . This seem to be in accordance with the recent data suggesting that activated AhR might form an E3 ubiquitin ligase complex inducing polyubiquitinylation and proteasomal degradation of b-catenin (Kawajiri et al., 2009) . However, we did not observe any effect of proteasome inhibitor on TCDD-induced downregulation of active-b-catenin in liver progenitor cells. This, together with a recent observation that activation of AhR does not reduce b-catenin in hepatoma cells (Braeuning et al., 2011) , suggests that this mode of AhR action might be cell-or tissue-specific. Additional mechanisms could be involved in downregulation of Wnt signaling activity in liver progenitors because TCDD induced a marked dephosphorylation of both Dvl2 and Dvl3 proteins playing a key role as the branching points regulating both canonical and noncanonical Wnt pathways (Angers and Moon, 2009) . Although the significance of individual phosphorylations of Dvl proteins is still largely unclear, it is known that activated Dvl proteins may stabilize b-catenin through regulation of Axin recruitment to LRP6 (Angers and Moon, 2009; Wallingford and Habas, 2005) .
When analyzing expression of the genes that are either directly (Axin2, Ccnd1, etc.) or indirectly (Cyp2e1) regulated by b-catenin, we found that sustained AhR activation by TCDD reduced expression of a number of Wnt/b-catenin targets (Fig. 5) . AhR has been proposed to participate in the regulation of adult stem cell compartments (Singh et al., 2009) . As the Wnt/b-catenin signaling plays a key role in maintaining stem cell phenotype (Kleber and Sommer, 2004; Reya et al., 2003; Sato et al., 2004) , we evaluated the impact of AhR-mediated deregulation of Wnt/b-catenin-dependent transcription on WB-F344 progenitor phenotype. Cytokeratins 14 and 19 are both abundantly expressed in oval cells, and the loss of their expression reflects differentiation into a more differentiated hepatoblast-like phenotype (Bisgaard et al., 1994; Golding et al., 1995) . We found that TCDD induced a significant reduction of both Krt14 and Krt19 mRNAs (Fig.  6) . In contrast, TCDD increased expression of Krt8, thus indicating cellular progression toward hepatocyte-like phenotype. TCDD also reduced expression of other genes associated with hepatic progenitor cell compartment, such as Kitl and Ncam1 (Fig. 6) . These results are in line with the evidence suggesting that downregulation of Wnt signaling promotes differentiation of mesenchymal stem cells into hepatocytes (Ke et al., 2008) . We further found that Krt19 mRNA was highly inducible by recombinant Wnt3a and that recombinant Wnt3a prevented the TCDD-induced downregulation of Krt19. Collectively, these results indicate that a sustained activation of AhR disrupts proliferation/differentiation balance in adult hepatic stem cell line, either directly or indirectly through the inhibition of Wnt/b-catenin signaling. Therefore, the observed deregulation of b-catenin signaling might link the AhR activation and altered phenotype/stemness of liver progenitor cells.
AhR activation may lead to reduced cell-cell adhesion and enhanced cell motility in various cancer models (Bui et al., 2009; Dietrich and Kaina, 2010; Diry et al., 2006) . We found that cells pretreated with TCDD show reduced adhesion and that a sustained TCDD treatment (up to 72 h) leads to a partial decrease in E-cadherin protein. We did not observe any early pronounced reduction of membrane-located b-catenin or E-cadherin immunostaining (data not shown), suggesting that a majority of adherens junctions are still intact in WB-F344 cells. However, we observed reduction of E-cadherin protein levels and enhanced G1-S cell cycle transition, when we simulated b-catenin depletion using the siRNA-mediated b-catenin knockdown. This indicated that destabilization of adherens junctions might contribute to the proliferative effects of AhR ligands. The disruption of b-catenin/E-cadherin interactions is also a mechanism, which might result in modulation of additional signaling pathways, including growth factor signaling (Heuberger and Birchmeier, 2010; Wheelock and Johnson, 2003) . Taken together, these results suggest that a sustained AhR activation may alter both Wnt/b-catenin signaling and b-catenin function in regulation of cell-to-cell adhesion.
In conclusion, the principle findings of the present study include our observations suggesting that: (1) AhR and Wnt/ b-catenin signaling may cooperate in induction of selected AhR transcriptional targets; (2) AhR ligands decrease ABC levels and induce further alterations of Wnt signaling, including dephosphorylation of Dvl, as well as downregulation of b-catenin-regulated genes in liver progenitor cells; and (3) activated AhR is associated both with deregulated liver progenitor phenotype and disrupted cell adhesion. Although the interplay of AhR activation and Wnt/b-catenin pathway could be limited to specific cell types, our results may help to understand some of the roles of both nonactivated and toxic ligand-activated AhR in less differentiated cell types, such as progenitor cell populations.
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